BMO Capital Maintains Reliance(RS.US) With Buy Rating, Cuts Target Price to $340
Buy Rating Justified by Reliance Steel's Strong Financials and Strategic Growth Initiatives
J.P. Morgan Maintains RenaissanceRe Holdings(RNR.US) With Hold Rating, Raises Target Price to $267
Wolfe Research Downgrades Reliance(RS.US) to Sell Rating, Announces Target Price $262
KeyBanc Maintains EMCOR Group(EME.US) With Hold Rating
Evercore Maintains RenaissanceRe Holdings(RNR.US) With Sell Rating, Raises Target Price to $218
Analysts Offer Insights on Financial Companies: First American Financial (FAF) and Renaissancere Holdings (RNR)
Evercore ISI Sticks to Its Sell Rating for Renaissancere Holdings (RNR)
Buy Rating Affirmed for Tenet Healthcare on Strong Financials and Growth Prospects
JPMorgan Adjusts Price Target on RenaissanceRe to $267 From $265, Maintains Neutral Rating
RenaissanceRe Price Target Raised to $267.00/Share From $265.00 by JP Morgan
RenaissanceRe Holdings Analyst Ratings
Tenet Healthcare Price Target Raised to $168.00/Share From $112.00 by Cantor Fitzgerald
Tenet Healthcare Analyst Ratings
Morgan Stanley Maintains RenaissanceRe Holdings(RNR.US) With Hold Rating, Maintains Target Price $240
Loop Capital Maintains Carlisle Companies(CSL.US) With Buy Rating, Maintains Target Price $475
Oppenheimer Maintains Carlisle Companies(CSL.US) With Buy Rating, Raises Target Price to $475
Carlisle Companies (CSL) Receives a Rating Update From a Top Analyst
Analysts Offer Insights on Industrial Goods Companies: Nordson (NDSN) and Carlisle Companies (CSL)
Truist Financial Maintains Tenet Healthcare(THC.US) With Buy Rating, Raises Target Price to $170